Pub Date : 2020-12-01Epub Date: 2020-12-21DOI: 10.1080/13685538.2020.1862078
Kumi Hirokawa, Yasuhito Fujii, Toshiyo Taniguchi, Jiro Takaki, Akizumi Tsutsumi
Objective: The purpose of the study was to investigate the association between andropause symptoms and sickness absence in Japanese male workers over 2 years.
Methods: A baseline survey asking about andropause symptoms, along with blood sampling for testosterone level, was conducted in June 2009. A total of 418 men (mean age = 52.4 years, SD = 8.6) participated and were followed through 2011. Hazard ratios (HRs) and 95% confidence intervals (CIs) for sickness absence were calculated using Cox proportional hazard models.
Results: During the follow-up period, 31 of 35 participants who took sickness absences had physical illnesses. A higher andropause symptom score was associated with an increased risk of sickness absence. Testosterone deficiency (<350 ng/dL) was not associated with sickness absence. Among the subscales of andropause symptoms, the somatic symptom score was positively associated with sickness absence, whereas testosterone deficiency combined with high sexual symptoms was not associated with sickness absence. Results were similar when limited to sickness absence because of physical illness. No significant interaction between andropause symptoms and testosterone deficiency was found.
Conclusions: Non-specific andropause symptoms unrelated to testosterone deficiency were positively associated with sickness absence.
{"title":"Andropause symptoms and sickness absence in Japanese male workers: a prospective study.","authors":"Kumi Hirokawa, Yasuhito Fujii, Toshiyo Taniguchi, Jiro Takaki, Akizumi Tsutsumi","doi":"10.1080/13685538.2020.1862078","DOIUrl":"https://doi.org/10.1080/13685538.2020.1862078","url":null,"abstract":"<p><strong>Objective: </strong>The purpose of the study was to investigate the association between andropause symptoms and sickness absence in Japanese male workers over 2 years.</p><p><strong>Methods: </strong>A baseline survey asking about andropause symptoms, along with blood sampling for testosterone level, was conducted in June 2009. A total of 418 men (mean age = 52.4 years, SD = 8.6) participated and were followed through 2011. Hazard ratios (HRs) and 95% confidence intervals (CIs) for sickness absence were calculated using Cox proportional hazard models.</p><p><strong>Results: </strong>During the follow-up period, 31 of 35 participants who took sickness absences had physical illnesses. A higher andropause symptom score was associated with an increased risk of sickness absence. Testosterone deficiency (<350 ng/dL) was not associated with sickness absence. Among the subscales of andropause symptoms, the somatic symptom score was positively associated with sickness absence, whereas testosterone deficiency combined with high sexual symptoms was not associated with sickness absence. Results were similar when limited to sickness absence because of physical illness. No significant interaction between andropause symptoms and testosterone deficiency was found.</p><p><strong>Conclusions: </strong>Non-specific andropause symptoms unrelated to testosterone deficiency were positively associated with sickness absence.</p>","PeriodicalId":55542,"journal":{"name":"Aging Male","volume":"23 5","pages":"1545-1552"},"PeriodicalIF":2.6,"publicationDate":"2020-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1080/13685538.2020.1862078","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"38733423","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2020-12-01Epub Date: 2020-05-20DOI: 10.1080/13685538.2020.1768367
İsa Ardahanlı, Mehmet Celik
Aim: Myocardial performance index (MPI) is an easy-to-apply and non-invasive method that shows both systolic and diastolic functions of the heart. In this study, it was aimed to evaluate the relationship between erectile dysfunction (ED) and MPI. Methods: The study included 45 male patients admitted to the urology outpatient clinic for ED and 48 healthy male volunteers. Echocardiographic evaluation of all participants was performed. Isovolumetric contraction time (IVCT), isovolumetric relaxation time (IVRT) and ejection time (ET) were measured. MPI was calculated using the IVCT + IVRT/ET formula. Results: The average age of the study population was 50 ± 5.3. Early diastolic mitral inflow (E)/late diastolic mitral inflow (A) ratio was significantly lower in the ED group (p ≤ 0.05). In the TDI evaluation between the groups, while early diastolic mitral annular velocity (Em) was significantly higher in the ED group, there was no significant difference in late diastolic mitral annular velocity (Am) and systolic peak velocities (Sm) (p < 0.01 and p = 0.417 and p = 0.092, respectively). While IVRT was significantly lower in the ED group (p < 0.05), there was no significant difference in IVCT and ET (p = 311 and p = 0.261, respectively). MPI was statistically significantly higher in the ED group (p < 0.05). Conclusion: ED has been found to affect MPI. This parameter, which is easily and non-invasively measured, can be used to predict the risk of CVDs in ED.
{"title":"Can myocardial performance index predict early cardiac risks in erectile dysfunction?","authors":"İsa Ardahanlı, Mehmet Celik","doi":"10.1080/13685538.2020.1768367","DOIUrl":"https://doi.org/10.1080/13685538.2020.1768367","url":null,"abstract":"<p><strong>Aim: </strong>Myocardial performance index (MPI) is an easy-to-apply and non-invasive method that shows both systolic and diastolic functions of the heart. In this study, it was aimed to evaluate the relationship between erectile dysfunction (ED) and MPI. <b>Methods:</b> The study included 45 male patients admitted to the urology outpatient clinic for ED and 48 healthy male volunteers. Echocardiographic evaluation of all participants was performed. Isovolumetric contraction time (IVCT), isovolumetric relaxation time (IVRT) and ejection time (ET) were measured. MPI was calculated using the IVCT + IVRT/ET formula. <b>Results:</b> The average age of the study population was 50 ± 5.3. Early diastolic mitral inflow (E)/late diastolic mitral inflow (A) ratio was significantly lower in the ED group (<i>p</i> ≤ 0.05). In the TDI evaluation between the groups, while early diastolic mitral annular velocity (Em) was significantly higher in the ED group, there was no significant difference in late diastolic mitral annular velocity (Am) and systolic peak velocities (Sm) (<i>p</i> < 0.01 and <i>p</i> = 0.417 and <i>p</i> = 0.092, respectively). While IVRT was significantly lower in the ED group (<i>p</i> < 0.05), there was no significant difference in IVCT and ET (<i>p</i> = 311 and <i>p</i> = 0.261, respectively). MPI was statistically significantly higher in the ED group (<i>p</i> < 0.05). <b>Conclusion:</b> ED has been found to affect MPI. This parameter, which is easily and non-invasively measured, can be used to predict the risk of CVDs in ED.</p>","PeriodicalId":55542,"journal":{"name":"Aging Male","volume":"23 5","pages":"1355-1361"},"PeriodicalIF":2.6,"publicationDate":"2020-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1080/13685538.2020.1768367","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"37953471","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Objective: To study the effect of ethanolic seed extract of Mucuna pruriens on damaged dorsal nerve of the penis (DNP) in aged rat in relation to penile erection.
Methods: The rats were divided into four groups Young (3 months), Aged (24 - 28 months), Aged + M. pruriens, and Young + M. pruriens (200 mg/kg b.w/60 days) and were subjected to the hypophysial - gonadal axis, nerve conduction velocity (NCV), and penile reflex. DNP sections were stained with nitric oxide synthase (nNOS), nicotinamide adenine dinucleotide phosphate (NaDPH) diaphorase, androgen receptor (AR), and osmium tetroxide. Terminal deoxynucleotidyl transferase (TdT) dUTP Nick-End Labeling (TUNEL) staining, electron microscopy(EM) and histometric analyses were done.
Results: Significant disturbance in hypophysial - gonadal axis was noted in aged rat. With reduced number of myelinated fibers, diameter, vacuolization, indentation of the myelin sheath, and degeneration. nNOS and its cofactor (NaDPH diaphorase) were reduced in aged rat DNP. NCV was slow in aged rats and concomitant poor penile reflex was also noted. AR showed reduced expression in aged rat DNP when compared to young and control groups. TUNEL positive cells were increased in aged rat DNP. These pathological changes were remarkably reduced or recovered in M. pruriens treated aged rats.
Conclusions: The results indicate a multi-factorial therapeutic activity in penile innervations towards sustaining the penile erection in the presence of the extract in aged rats and justifying the claim of traditional usage.
{"title":"Therapeutic potential of <i>Mucuna pruriens</i> (Linn.) on ageing induced damage in dorsal nerve of the penis and its implication on erectile function: an experimental study using albino rats.","authors":"Prakash Seppan, Ibrahim Muhammed, Karthik Ganesh Mohanraj, Ganesh Lakshmanan, Dinesh Premavathy, Sakthi Jothi Muthu, Khayinmi Wungmarong Shimray, Sathya Bharathy Sathyanathan","doi":"10.1080/13685538.2018.1439005","DOIUrl":"https://doi.org/10.1080/13685538.2018.1439005","url":null,"abstract":"<p><strong>Objective: </strong>To study the effect of ethanolic seed extract of <i>Mucuna pruriens</i> on damaged dorsal nerve of the penis (DNP) in aged rat in relation to penile erection.</p><p><strong>Methods: </strong>The rats were divided into four groups Young (3 months), Aged (24 - 28 months), Aged + <i>M. pruriens,</i> and Young + <i>M. pruriens</i> (200 mg/kg b.w/60 days) and were subjected to the hypophysial - gonadal axis, nerve conduction velocity (NCV), and penile reflex. DNP sections were stained with nitric oxide synthase (nNOS), nicotinamide adenine dinucleotide phosphate (NaDPH) diaphorase, androgen receptor (AR), and osmium tetroxide. Terminal deoxynucleotidyl transferase (TdT) dUTP Nick-End Labeling (TUNEL) staining, electron microscopy(EM) and histometric analyses were done.</p><p><strong>Results: </strong>Significant disturbance in hypophysial - gonadal axis was noted in aged rat. With reduced number of myelinated fibers, diameter, vacuolization, indentation of the myelin sheath, and degeneration. nNOS and its cofactor (NaDPH diaphorase) were reduced in aged rat DNP. NCV was slow in aged rats and concomitant poor penile reflex was also noted. AR showed reduced expression in aged rat DNP when compared to young and control groups. TUNEL positive cells were increased in aged rat DNP. These pathological changes were remarkably reduced or recovered in <i>M. pruriens</i> treated aged rats.</p><p><strong>Conclusions: </strong>The results indicate a multi-factorial therapeutic activity in penile innervations towards sustaining the penile erection in the presence of the extract in aged rats and justifying the claim of traditional usage.</p>","PeriodicalId":55542,"journal":{"name":"Aging Male","volume":"23 5","pages":"313-326"},"PeriodicalIF":2.6,"publicationDate":"2020-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1080/13685538.2018.1439005","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"35834082","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Several questionnaires have been developed to assist the diagnostic process in obstructive sleep apnea syndrome (OSAS). Berlin Sleep Questionnaire (BSQ) represents a validated screening tool for OSAS. Totally 450 patients admitted to the Sleep Center at Dicle University Medical Faculty were included prospectively. A risk analysis was performed for presence of OSAS using the BSQ. Arterial blood gas measurements were performed including bicarbonate (HCO3) level. The sensitivity, specificity, positive predictive value (PPV) and negative predictive value (NPV) of BSQ for presence of OSAS and severe OSAS were determined. In patients with arterial HCO3 >24.94 mEq/L; sensitivity, specificity, PPV and NPV, of the BSQ were 93.04, 57.1, 98.3, and 23.5%, respectively. The addition of arterial HCO3 value increased the sensitivity of the BSQ in detecting OSAS patients. Although the cost of sleep studies is high for false positives from the BSQ plus arterial HCO3 level, this cost should be compared with the loss of work efficiency and severe healthcare costs of undiagnosed cases in the future. Therefore, finding possible OSAS cases in primary care health centers is important and adding serum HCO3 value to BSQ questionnaire may contribute to this topic.
{"title":"Serum bicarbonate level improves specificity of Berlin Sleep Questionnaire for obstructive sleep apnea.","authors":"Mazlum Dursun, Hadice Selimoğlu Şen, Süreyya Yılmaz, Melike Demir, Gökhan Kırbaş, Mahşuk Taylan","doi":"10.1080/13685538.2020.1801623","DOIUrl":"https://doi.org/10.1080/13685538.2020.1801623","url":null,"abstract":"<p><p>Several questionnaires have been developed to assist the diagnostic process in obstructive sleep apnea syndrome (OSAS). Berlin Sleep Questionnaire (BSQ) represents a validated screening tool for OSAS. Totally 450 patients admitted to the Sleep Center at Dicle University Medical Faculty were included prospectively. A risk analysis was performed for presence of OSAS using the BSQ. Arterial blood gas measurements were performed including bicarbonate (HCO3) level. The sensitivity, specificity, positive predictive value (PPV) and negative predictive value (NPV) of BSQ for presence of OSAS and severe OSAS were determined. In patients with arterial HCO<sub>3</sub> >24.94 mEq/L; sensitivity, specificity, PPV and NPV, of the BSQ were 93.04, 57.1, 98.3, and 23.5%, respectively. The addition of arterial HCO<sub>3</sub> value increased the sensitivity of the BSQ in detecting OSAS patients. Although the cost of sleep studies is high for false positives from the BSQ plus arterial HCO3 level, this cost should be compared with the loss of work efficiency and severe healthcare costs of undiagnosed cases in the future. Therefore, finding possible OSAS cases in primary care health centers is important and adding serum HCO3 value to BSQ questionnaire may contribute to this topic.</p>","PeriodicalId":55542,"journal":{"name":"Aging Male","volume":"23 5","pages":"1480-1486"},"PeriodicalIF":2.6,"publicationDate":"2020-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1080/13685538.2020.1801623","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"38229387","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2020-12-01Epub Date: 2020-08-26DOI: 10.1080/13685538.2020.1800630
Amira Nasser Al Hail, Nasfareen Zada, Ahmad Al-Juboori, Asharaf Ayinikunnan
Background: Anomaly of internal carotid artery (ICA) is a very rare variation. In almost all the cases, the anomaly was on the right side. This right-sided predominance may be attributed to anatomical influences and factors affecting blood pressure.
Case report: A 67-years-old man presented to ear, nose and throat (ENT) outpatient clinic in Al Wakra Hospital complain of sore throat, there was associated medical co-morbidities (diabetic, hypertensive, hyperlipidemia and coronary artery diseases). ENT examination showed a pulsating, bulging mass on the right posterolateral oropharyngeal wall with normal mucosal covering. CT scan with contrast showed aberrant course of the right ICA which is coursing medially in prevertebral space and right posterolateral hypopharyngeal wall over a length of approximately 1.7 cm, making an acute U-turn before resuming the normal course and its distal aspects, only a thin layer of mucosa noted over the aberrant course of ICA.
Conclusion: Anomaly of ICA must be kept in mind in the evaluation of patients with sore throat associated with oropharyngeal mass especially in old-aged patients with atherosclerotic diseases.
{"title":"Internal carotid artery anomaly in oropharynx as a rare cause of sore throat.","authors":"Amira Nasser Al Hail, Nasfareen Zada, Ahmad Al-Juboori, Asharaf Ayinikunnan","doi":"10.1080/13685538.2020.1800630","DOIUrl":"https://doi.org/10.1080/13685538.2020.1800630","url":null,"abstract":"<p><strong>Background: </strong>Anomaly of internal carotid artery (ICA) is a very rare variation. In almost all the cases, the anomaly was on the right side. This right-sided predominance may be attributed to anatomical influences and factors affecting blood pressure.</p><p><strong>Case report: </strong>A 67-years-old man presented to ear, nose and throat (ENT) outpatient clinic in Al Wakra Hospital complain of sore throat, there was associated medical co-morbidities (diabetic, hypertensive, hyperlipidemia and coronary artery diseases). ENT examination showed a pulsating, bulging mass on the right posterolateral oropharyngeal wall with normal mucosal covering. CT scan with contrast showed aberrant course of the right ICA which is coursing medially in prevertebral space and right posterolateral hypopharyngeal wall over a length of approximately 1.7 cm, making an acute U-turn before resuming the normal course and its distal aspects, only a thin layer of mucosa noted over the aberrant course of ICA.</p><p><strong>Conclusion: </strong>Anomaly of ICA must be kept in mind in the evaluation of patients with sore throat associated with oropharyngeal mass especially in old-aged patients with atherosclerotic diseases.</p>","PeriodicalId":55542,"journal":{"name":"Aging Male","volume":"23 5","pages":"1467-1470"},"PeriodicalIF":2.6,"publicationDate":"2020-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1080/13685538.2020.1800630","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"38308534","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2020-12-01Epub Date: 2020-02-05DOI: 10.1080/13685538.2020.1718637
Li Zhou, Xinglong Liang, Kaizhong Zhang
Objective: In this study, we aimed to examine the clinical efficacy of simultaneous transurethral resection of bladder cancer and the prostate (TURBT + TURP) in non-muscle invasive bladder cancer (NMIBC) and benign prostatic hyperplasia (BPH) patients.
Method: We conducted systematic research in PubMed, EMBASE, and Cochrane Library databases to identify retrospective studies and prospective randomized controlled trials (RCTs) comparing patient outcomes between TURBT + TURP and TURBT-only patients. The meta-analysis was conducted using Review Manager 5.3.
Results: We identified eight relevant studies involving a total of 1032 patients. We found that patients that underwent TURBT + TURP exhibited significantly lower recurrence rates [odds ratio (OR), 0.70; 95% confidence interval (CI), 0.53-0.93; p = .01] and increased maximal urinary flow rate (Qmax) (WMD, 5.92; 95% CI, 4.67-7.16; p < .001) compared with patients that underwent TURBT-only. However, rates of recurrence at the prostatic urethra/bladder neck and bladder tumor progression, as well as the time to recurrence did not differ significantly between these two groups.
Conclusions: Simultaneous TURBT + TURP can be safely performed in patients with NMIBC and BPH and improves patient quality of life, without any risk of increasing tumor recurrence or metastasis rates. Comprehensive RCTs are needed to confirm the results of this study.
{"title":"Assessment of the clinical efficacy of simultaneous transurethral resection of both bladder cancer and the prostate: a systematic review and meta-analysis.","authors":"Li Zhou, Xinglong Liang, Kaizhong Zhang","doi":"10.1080/13685538.2020.1718637","DOIUrl":"https://doi.org/10.1080/13685538.2020.1718637","url":null,"abstract":"<p><strong>Objective: </strong>In this study, we aimed to examine the clinical efficacy of simultaneous transurethral resection of bladder cancer and the prostate (TURBT + TURP) in non-muscle invasive bladder cancer (NMIBC) and benign prostatic hyperplasia (BPH) patients.</p><p><strong>Method: </strong>We conducted systematic research in PubMed, EMBASE, and Cochrane Library databases to identify retrospective studies and prospective randomized controlled trials (RCTs) comparing patient outcomes between TURBT + TURP and TURBT-only patients. The meta-analysis was conducted using Review Manager 5.3.</p><p><strong>Results: </strong>We identified eight relevant studies involving a total of 1032 patients. We found that patients that underwent TURBT + TURP exhibited significantly lower recurrence rates [odds ratio (OR), 0.70; 95% confidence interval (CI), 0.53-0.93; <i>p</i> = .01] and increased maximal urinary flow rate (Qmax) (WMD, 5.92; 95% CI, 4.67-7.16; <i>p</i> < .001) compared with patients that underwent TURBT-only. However, rates of recurrence at the prostatic urethra/bladder neck and bladder tumor progression, as well as the time to recurrence did not differ significantly between these two groups.</p><p><strong>Conclusions: </strong>Simultaneous TURBT + TURP can be safely performed in patients with NMIBC and BPH and improves patient quality of life, without any risk of increasing tumor recurrence or metastasis rates. Comprehensive RCTs are needed to confirm the results of this study.</p>","PeriodicalId":55542,"journal":{"name":"Aging Male","volume":"23 5","pages":"1182-1193"},"PeriodicalIF":2.6,"publicationDate":"2020-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1080/13685538.2020.1718637","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"37611999","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Objective: To investigate the safety and efficacy of wide local excision combined with aminolevulinic acid (ALA) photodynamic therapy (PDT) for the treatment of scrotal Paget's disease in patients of advanced age.
Methods: Data were collected for 16 patients (mean age, 68.44 years) with scrotal Paget's disease treated with wide local excision combined with ALA PDT and followed up from June 2014 to February 2018. Pathological examination after wide local excision confirmed Paget's disease. The patients underwent three courses of ALA PDT postoperatively and were followed up to determine the curative effect and complications in the short and middle term.
Results: The disease duration ranged from 4 to 76 months (mean, 36 months). Ten patients underwent simple excision, six underwent skin flap transfer, and two required reoperations due to skin flap necrosis and infection. The patients were followed up for 3 to 42 months after ALA PDT, during which time two patients developed metastasis (recurrence rate, 12.50%). No other serious complications occurred during follow-up except for lower limb movement disorder in one patient (6.25%).
Conclusions: Wide local excision combined with ALA PDT shows good clinical efficacy and a low complication rate in patients of advanced age with scrotal Paget's disease.
{"title":"Excision combined with photodynamic therapy for scrotal Paget's disease in patients aged over 60 years.","authors":"Mingquan Chen, Xiong Chen, Yuanqing Dai, Zhiming Yang, Xiaobo Zhang, Dongjie Li","doi":"10.1080/13685538.2019.1607284","DOIUrl":"https://doi.org/10.1080/13685538.2019.1607284","url":null,"abstract":"<p><strong>Objective: </strong>To investigate the safety and efficacy of wide local excision combined with aminolevulinic acid (ALA) photodynamic therapy (PDT) for the treatment of scrotal Paget's disease in patients of advanced age.</p><p><strong>Methods: </strong>Data were collected for 16 patients (mean age, 68.44 years) with scrotal Paget's disease treated with wide local excision combined with ALA PDT and followed up from June 2014 to February 2018. Pathological examination after wide local excision confirmed Paget's disease. The patients underwent three courses of ALA PDT postoperatively and were followed up to determine the curative effect and complications in the short and middle term.</p><p><strong>Results: </strong>The disease duration ranged from 4 to 76 months (mean, 36 months). Ten patients underwent simple excision, six underwent skin flap transfer, and two required reoperations due to skin flap necrosis and infection. The patients were followed up for 3 to 42 months after ALA PDT, during which time two patients developed metastasis (recurrence rate, 12.50%). No other serious complications occurred during follow-up except for lower limb movement disorder in one patient (6.25%).</p><p><strong>Conclusions: </strong>Wide local excision combined with ALA PDT shows good clinical efficacy and a low complication rate in patients of advanced age with scrotal Paget's disease.</p>","PeriodicalId":55542,"journal":{"name":"Aging Male","volume":"23 5","pages":"854-859"},"PeriodicalIF":2.6,"publicationDate":"2020-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1080/13685538.2019.1607284","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"37370241","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2020-12-01Epub Date: 2019-06-28DOI: 10.1080/13685538.2019.1631273
Suleyman Sahin, Fatih Karataş
Sir, We greatly appreciated one of the recently published article entitled Does plasma thiol and disulphide be a new marker for prostate cancer in prostate-specific antigen level between 10 and 20ng/mL by Topaktas et al. in your journal. The authors performed a prospective study investigating the plasma total thiol (TT), native thiol (NT), and disulfide (SS) levels as potential new biomarkers for the diagnosis of prostate cancer (PC), combining serum TT, NT, and SS levels with serum PSA measurements in 76 participants with elevated PSA levels ranging 0–20ng/mL, and further concluding that serum TT levels may help guide detecting PC, particularly with PSA levels between 10 and 20ng/ml [1]. However, we would like to kindly challenge some of the findings of the study as there seems to be confusing and conflicting parts as indicated below. As previously and generally shown in the literature, serum TT, NT, and SS levels were found to be significantly low in benign proliferative pathologies and cancer disease compared to healthy subjects and also shown to be independent predictors of poor survival [2,3]. In the present study, the authors found serum TT, NT, and SS levels higher in Group 1 than those of Group 2, with no significant difference. However, in the discussion part, they reported the following conclusion; “although not statistically significant, when PSA levels were between 10 and 20 (group 2), serum TT and NT levels were found to be high” as indicated by their own words in the manuscript. The results and conclusion appear to be discordant, hence having a likelihood of a huge confounder. How do the authors explain these inconsistent findings? One another important finding needs to be clarified is that authors have mentioned from a recent study [4] investigating the role of thiol/disulfide homeostasis in the differentiation of benign diseases from PC, which concluded that serum TT and NT levels were significantly higher in patients with PC than those found in patients with benign diseases. Of course, the literature can include various results; however, in order to support their results, the authors have cited another paper [5], which evaluated thiol/disulfide homeostasis prior to and 6months following radical prostatectomy in PC patients reporting that decreased TT and total antioxidant status levels weakened anti-oxidant defense mechanism in patients with PC, and further concluding that increased oxidative stress in PC patients may have a role in the etiopathogenesis of PC. However, the results of the two studies mentioned in the manuscript oppose to each other, hence need to be clarified. There are deficiencies in terms of Material – Method. The authors did not specify whether serum samples were obtained immediately by centrifugation and the Celcius degree to which they were stored. Moreover, another important point is that the researchers did not state whether they stored serum samples for the same period on average, according to the PSA gro
{"title":"Plasma thiols in prostate cancer.","authors":"Suleyman Sahin, Fatih Karataş","doi":"10.1080/13685538.2019.1631273","DOIUrl":"https://doi.org/10.1080/13685538.2019.1631273","url":null,"abstract":"Sir, We greatly appreciated one of the recently published article entitled Does plasma thiol and disulphide be a new marker for prostate cancer in prostate-specific antigen level between 10 and 20ng/mL by Topaktas et al. in your journal. The authors performed a prospective study investigating the plasma total thiol (TT), native thiol (NT), and disulfide (SS) levels as potential new biomarkers for the diagnosis of prostate cancer (PC), combining serum TT, NT, and SS levels with serum PSA measurements in 76 participants with elevated PSA levels ranging 0–20ng/mL, and further concluding that serum TT levels may help guide detecting PC, particularly with PSA levels between 10 and 20ng/ml [1]. However, we would like to kindly challenge some of the findings of the study as there seems to be confusing and conflicting parts as indicated below. As previously and generally shown in the literature, serum TT, NT, and SS levels were found to be significantly low in benign proliferative pathologies and cancer disease compared to healthy subjects and also shown to be independent predictors of poor survival [2,3]. In the present study, the authors found serum TT, NT, and SS levels higher in Group 1 than those of Group 2, with no significant difference. However, in the discussion part, they reported the following conclusion; “although not statistically significant, when PSA levels were between 10 and 20 (group 2), serum TT and NT levels were found to be high” as indicated by their own words in the manuscript. The results and conclusion appear to be discordant, hence having a likelihood of a huge confounder. How do the authors explain these inconsistent findings? One another important finding needs to be clarified is that authors have mentioned from a recent study [4] investigating the role of thiol/disulfide homeostasis in the differentiation of benign diseases from PC, which concluded that serum TT and NT levels were significantly higher in patients with PC than those found in patients with benign diseases. Of course, the literature can include various results; however, in order to support their results, the authors have cited another paper [5], which evaluated thiol/disulfide homeostasis prior to and 6months following radical prostatectomy in PC patients reporting that decreased TT and total antioxidant status levels weakened anti-oxidant defense mechanism in patients with PC, and further concluding that increased oxidative stress in PC patients may have a role in the etiopathogenesis of PC. However, the results of the two studies mentioned in the manuscript oppose to each other, hence need to be clarified. There are deficiencies in terms of Material – Method. The authors did not specify whether serum samples were obtained immediately by centrifugation and the Celcius degree to which they were stored. Moreover, another important point is that the researchers did not state whether they stored serum samples for the same period on average, according to the PSA gro","PeriodicalId":55542,"journal":{"name":"Aging Male","volume":"23 5","pages":"914"},"PeriodicalIF":2.6,"publicationDate":"2020-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1080/13685538.2019.1631273","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"37376977","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2020-12-01Epub Date: 2019-07-03DOI: 10.1080/13685538.2019.1634044
Lingyan Chen, Yu Hu
Introduction: Thyroid dysfunction is closely associated with skeletal muscle weakness. However, data on the optimal serum range of thyroid hormones for maintaining muscle strength in the elderly is lacking.
Methods: We conducted a cross-sectional analysis in male elderly inpatients from the Geriatric Department of Zhongshan Hospital (affiliated to Fudan University, Shanghai, China). Serum biochemical parameters and thyroid hormones were detected for each participant. Hand grip (HG) was measured, with low hand grip defined as HG <26 kg according to the standard of the Asian Working Group for Sarcopenia. Logistic regression was used to evaluate the effects of different serum thyroid hormone levels on HG.
Results: The majority of the subjects were euthyroid. The prevalence of low hand grip was 48.5%. Stratified by the free thyroxine (FT4) quartiles, the results showed HG was the highest in the third quartile. Multiple logistic regression analysis showed that compared with those in the first quartile, subjects in the third quartile of FT4 had a significantly lower risk of low hand grip (OR = 0.133, 95%CI: 0.020-0.610, p = .009), after adjusting potential confounding factors.
Conclusion: In elderly male inpatients, maintaining a narrower serum range of thyroid hormone might be needed to protect skeletal muscle strength.
甲状腺功能障碍与骨骼肌无力密切相关。然而,关于维持老年人肌肉力量的甲状腺激素的最佳血清范围的数据缺乏。方法:对复旦大学附属中山医院老年科住院的男性老年患者进行横断面分析。检测每位受试者的血清生化指标和甲状腺激素。测量了手握力(HG),将低手握力定义为HG结果:大多数受试者甲状腺功能正常。低握手率为48.5%。按游离甲状腺素(FT4)四分位数分层,结果显示HG在第三四分位数最高。多元logistic回归分析显示,在调整潜在混杂因素后,FT4的第三四分位受试者的低握力风险显著低于第一四分位受试者(OR = 0.133, 95%CI: 0.020-0.610, p = 0.009)。结论:在老年男性住院患者中,维持较窄的血清甲状腺激素范围可能是保护骨骼肌力量的必要条件。
{"title":"The correlation between serum thyroid hormone levels and hand grip among elderly male Chinese inpatients.","authors":"Lingyan Chen, Yu Hu","doi":"10.1080/13685538.2019.1634044","DOIUrl":"https://doi.org/10.1080/13685538.2019.1634044","url":null,"abstract":"<p><strong>Introduction: </strong>Thyroid dysfunction is closely associated with skeletal muscle weakness. However, data on the optimal serum range of thyroid hormones for maintaining muscle strength in the elderly is lacking.</p><p><strong>Methods: </strong>We conducted a cross-sectional analysis in male elderly inpatients from the Geriatric Department of Zhongshan Hospital (affiliated to Fudan University, Shanghai, China). Serum biochemical parameters and thyroid hormones were detected for each participant. Hand grip (HG) was measured, with low hand grip defined as HG <26 kg according to the standard of the Asian Working Group for Sarcopenia. Logistic regression was used to evaluate the effects of different serum thyroid hormone levels on HG.</p><p><strong>Results: </strong>The majority of the subjects were euthyroid. The prevalence of low hand grip was 48.5%. Stratified by the free thyroxine (FT4) quartiles, the results showed HG was the highest in the third quartile. Multiple logistic regression analysis showed that compared with those in the first quartile, subjects in the third quartile of FT4 had a significantly lower risk of low hand grip (OR = 0.133, 95%CI: 0.020-0.610, <i>p</i> = .009), after adjusting potential confounding factors.</p><p><strong>Conclusion: </strong>In elderly male inpatients, maintaining a narrower serum range of thyroid hormone might be needed to protect skeletal muscle strength.</p>","PeriodicalId":55542,"journal":{"name":"Aging Male","volume":"23 5","pages":"928-933"},"PeriodicalIF":2.6,"publicationDate":"2020-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1080/13685538.2019.1634044","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"37385526","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2020-12-01Epub Date: 2018-11-21DOI: 10.1080/13685538.2018.1541979
Suleyman Sami Cakir, Levent Ozcan, Emre Can Polat, Huseyin Besiroglu, Ramazan Kocaaslan, Alper Ötunctemur, Emin Ozbek
Objective: To compare the efficacy of statins and ɑ blockers drug therapies for benign prostatic hyperplasia (BPH) in patients with metabolic syndrome (MetS).
Materials and method: A total of three hundred patients were randomly distributed into three groups of one hundred patients each. Group 1 received only ɑ-adrenoceptor antagonist (ɑ-blocker, AB) (Tamsulosin), group 2 received only statin (atorvastatin), and group 3 received AB plus statin (Tamsulosin + Atorvastatin). The efficacy measurement was assessed by analyzing the changes from baseline in the total International Prostate Symptom Score (IPSS), disease-specific QoL question score and maximum urinary flow rate at the end of 6 months in each group and between the three groups.
Results: Pre-treatment and post-treatment value of triglycerides (TG), high-density lipoprotein (HDL), and prostate volüme (PV) were not significantly different in AB group, while TG and PV were significantly lower in patients taking statin and combined therapy. The significant decrease was demonstrated in maximum urinary flow rate (Qmax) in three groups. However, the most significant decrease was observed in the combination therapy group. IPSS, postvoid residual urine volüme (PVR), and Quality of Life score (QoL) significantly changed in three groups.
Conclusion: We recommend of the use of statins in those men with BPH accompanied by MetS in which AB is ineffective alone.
{"title":"Statins are effective in the treatment of benign prostatic hyperplasia with metabolic syndrome.","authors":"Suleyman Sami Cakir, Levent Ozcan, Emre Can Polat, Huseyin Besiroglu, Ramazan Kocaaslan, Alper Ötunctemur, Emin Ozbek","doi":"10.1080/13685538.2018.1541979","DOIUrl":"https://doi.org/10.1080/13685538.2018.1541979","url":null,"abstract":"<p><strong>Objective: </strong>To compare the efficacy of statins and ɑ blockers drug therapies for benign prostatic hyperplasia (BPH) in patients with metabolic syndrome (MetS).</p><p><strong>Materials and method: </strong>A total of three hundred patients were randomly distributed into three groups of one hundred patients each. Group 1 received only ɑ-adrenoceptor antagonist (ɑ-blocker, AB) (Tamsulosin), group 2 received only statin (atorvastatin), and group 3 received AB plus statin (Tamsulosin + Atorvastatin). The efficacy measurement was assessed by analyzing the changes from baseline in the total International Prostate Symptom Score (IPSS), disease-specific QoL question score and maximum urinary flow rate at the end of 6 months in each group and between the three groups.</p><p><strong>Results: </strong>Pre-treatment and post-treatment value of triglycerides (TG), high-density lipoprotein (HDL), and prostate volüme (PV) were not significantly different in AB group, while TG and PV were significantly lower in patients taking statin and combined therapy. The significant decrease was demonstrated in maximum urinary flow rate (<i>Q</i><sub>max</sub>) in three groups. However, the most significant decrease was observed in the combination therapy group. IPSS, postvoid residual urine volüme (PVR), and Quality of Life score (QoL) significantly changed in three groups.</p><p><strong>Conclusion: </strong>We recommend of the use of statins in those men with BPH accompanied by MetS in which AB is ineffective alone.</p>","PeriodicalId":55542,"journal":{"name":"Aging Male","volume":"23 5","pages":"538-543"},"PeriodicalIF":2.6,"publicationDate":"2020-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1080/13685538.2018.1541979","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"36754879","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}